DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 075387
NDA 075387 describes FLOXURIDINE, which is a drug marketed by Fresenius Kabi Usa, Pharmaforce, and West-ward Pharms Int, and is included in three NDAs. It is available from two suppliers. Additional details are available on the FLOXURIDINE profile page.
The generic ingredient in FLOXURIDINE is floxuridine. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the floxuridine profile page.
The generic ingredient in FLOXURIDINE is floxuridine. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the floxuridine profile page.
Summary for 075387
| Tradename: | FLOXURIDINE |
| Applicant: | West-ward Pharms Int |
| Ingredient: | floxuridine |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 075387
| Ingredient-type | Deoxyuridine |
Medical Subject Heading (MeSH) Categories for 075387
Suppliers and Packaging for NDA: 075387
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FLOXURIDINE | floxuridine | INJECTABLE;INJECTION | 075387 | ANDA | West-Ward Pharmaceuticals Corp | 0143-9270 | N | 0143-9270-01 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
| Approval Date: | Apr 16, 2000 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
